OSI SYSTEMS INC

OSI Systems, Inc. is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications, operating in diversified markets including homeland security, healthcare, defense and aerospace. The company has three operating divisions: Security, providing security and inspection systems and turnkey security screening solutions; Optoelectronics and Manufacturing, providing specialized electronic components and electronics manufacturing services; and Healthcare, providing patient monitoring, cardiology and remote monitoring, and connected care systems. The Security division accounted for 70% of total consolidated revenues for fiscal 2025, the Optoelectronics and Manufacturing division accounted for 20%, and the Healthcare division accounted for 10%. The company believes the market for security and inspection products will continue to be affected by the threat of terrorist incidents, drug and human trafficking, border security, gun violence, and by new government mandates and appropriations both in the United States and internationally. Global initiatives like the European Union’s Customs Control Equipment Instrument (CCEI) and mandates for 100% cargo scanning at key international ports are driving increased demand for advanced inspection technologies. The company believes that the healthcare industry will continue to grow throughout much of the world, driven by developing countries building healthcare infrastructure and aging populations in developed areas.

The company faces aggressive competition in each of its operating divisions. In the security and inspection market, competition is based primarily on factors such as product performance specification standards, quality and reliability, maintenance and repair competency, government regulatory approvals and qualifications, overall cost effectiveness, prior customer relationships and reputation, technological capabilities, price, local market presence, historical program execution experience, and breadth of sales and service organization. The company believes it can supply a variety of system types and offers among the widest array of security inspection solutions available from a single supplier. In the patient monitoring, cardiology and remote monitoring, and connected care markets, competition is based on product performance, functionality, value and breadth of sales and service organization. The company believes its patient monitoring products are easier to use than many competitors' products due to a consistent user interface, and that the capability of its monitoring systems to connect together and to the hospital infrastructure is a key competitive advantage. In the optoelectronic devices and electronics manufacturing services markets, customers evaluate the company and its competitors based on expertise in design and development, product quality, timely delivery, pricing, technical support, and the ability to offer fully integrated services. The company believes its vertical integration differentiates it from many competitors and provides value to customers who can rely on it as an integrated and comprehensive supplier.

The company generates revenue through three operating divisions. The Security division provides security screening products, multi-platform software solutions, and services globally, as well as turnkey security screening solutions, used to inspect baggage, parcels, cargo, people, vehicles and other objects for weapons, explosives, drugs, radioactive and nuclear materials and other contraband. The Optoelectronics and Manufacturing division designs, manufactures and markets optoelectronic devices and flex circuits and provides electronics manufacturing services globally for use in a broad range of applications, including aerospace and defense electronics, security and inspection systems, medical imaging and diagnostics, telecommunications, office automation, computer peripherals, industrial automation, and consumer products, and also provides these services to the company's own Security and Healthcare divisions. The Healthcare division designs, manufactures, markets and services patient monitoring, cardiology and remote monitoring, and connected care systems globally for sale primarily to hospitals and medical centers. The company recognizes revenue when performance obligations under the terms of contracts with customers are satisfied, with performance obligations broadly categorized as product sales, service revenue, and project-specific contract revenue. Revenue from sales of products is recognized upon shipment or delivery when control of the product transfers to the customer, and revenue from services is generally recognized over time as the services are performed.

The Security division's products are used to inspect baggage, parcels, cargo, people, vehicles and other objects for various contraband and prohibited items including weapons, explosives, drugs, biosecurity threats, and nuclear materials, and are also used for verification of cargo manifests. Security products fall into categories including baggage and parcel inspection; cargo and vehicle inspection; hold (checked) baggage screening; people screening; radiation monitoring; explosive and narcotics trace detection; optical inspection systems; and radio frequency (RF) equipment. The division also offers turnkey security screening services, as well as related software integration platforms, operator training, and the staffing and operation of security screening checkpoints under the “S2” trade name. Many security and inspection systems utilize dual-energy X-ray imaging technology, and some systems also use multi-view and computed tomography. Cargo and vehicle inspection systems are designed in various configurations including mobile, portal, gantry, and rail systems. The division also offers trace detection systems designed to detect trace amounts of explosives and narcotics and people screening products such as walk-through metal detectors. The division advances the application of radio frequency (RF) broadcast transmission and scientific and industrial equipment. For the fiscal year ended June 30, 2025, the Security division's direct sales to the U.S. Government were approximately $182.8 million ¹.

The Optoelectronics and Manufacturing division's optoelectronic devices consist of both active and passive components, with active components detecting lights of different wavelengths and converting light into electrical signals, and another set of devices emitting light in the form of lasers. Passive components are responsible for amplifying, separating, and reflecting light. These products are manufactured in standard and customized configurations and are offered either as components or as subsystems, provided primarily under the “OSI Optoelectronics,” “OSI LaserDiode,” and “Advanced Photonix” trade names. The division also provides electronics design and manufacturing services in North America, the United Kingdom, and the Asia Pacific region, including printed circuit boards, cable and harness assemblies, and complete systems, offered under the trade names “OSI Electronics,” “APlus Products,” “Altaflex,” and “PFC Flexible Circuits.” The Healthcare division designs, manufactures and markets products globally primarily under the “Spacelabs Healthcare” trade name, including patient monitors for use in perioperative, critical care, step down and emergency care environments, bedside monitors such as the Xprezzon and Qube, telemetry solutions, centralized surveillance solutions (Xhibit Central Station), and products integrated into hospital information systems via Intesys Clinical Suite (ICS). The division also offers Spacelabs SafeNSound, predictive analytics clinical decision support tools featuring the Rothman Index, Pathfinder SL and Lifescreen Pro analysis tools, Eclipse Pro Holter recorders, Eclipse Mini Ambulatory ECG Recorders, ambulatory blood pressure (ABP) monitors, the Sentinel Cardiology Information Management System, and multivendor compatible accessories.

During fiscal 2025, the company acquired two businesses, and during fiscal 2024, it acquired two businesses, none of which were considered material. In July 2024, the company issued an aggregate of $350.0 million ² principal amount of 2.25% ³ convertible senior notes due in August 2029. During fiscal 2025, the company repurchased 531,314 ⁴ shares of common stock for $80.4 million ⁵. As of June 30, 2025, the maximum number of shares of common stock that may yet be purchased under the current plan authorized by the Board of Directors is 1,190,556 ⁶. Subsequent to June 30, 2025, in July 2025, the company amended and extended its credit facility, now maturing in July 2030, and paid down the delayed draw term loan. The company is in the process of implementing a new company-wide ERP system.

For fiscal 2025, the company reported consolidated net revenue of $1,713.2 million ⁷, an 11.3% ⁸ increase compared to the prior year. Income from operations increased to $217.5 million ⁹ in fiscal 2025, representing 15% ¹⁰ growth from the prior year, driven primarily by increased net revenue of $174.4 million ¹¹ which increased associated gross profit by $56.7 million ¹², partially offset by an increase in operating expenses of $28.3 million ¹³. Net income was $149.6 million ¹⁴ and diluted EPS was $8.71 ¹⁵ compared to $7.38 ¹⁶ in the prior year. Gross profit increased approximately $56.7 million ¹⁷ in fiscal 2025 as compared to the prior year on an 11.3% ¹⁸ increase in net revenue, with gross margin relatively comparable to the prior year at 34.3% ¹⁹ of net revenues. Cash provided by operations was $97.6 million ²⁰ compared to cash used in operations of $87.5 million ²¹ in the prior fiscal year.

The company intends to capitalize on opportunities to replace, service and upgrade existing security installations, and to offer turnkey security screening solutions in which it may construct, staff and/or operate security screening checkpoints for customers. The company expects that a market for software-as-a-service (SaaS) platforms capable of integrating data from security inspection systems with related information will continue to develop, mature and grow, particularly as customers shift to secure, cloud-based, networking technologies. The company is a leader in the development of these platforms, including the transmission of data to operators working within secure, remote screening facilities. The company's software has been used by customs and tax authorities in the United States, Europe and Latin America to screen millions of containers and vehicles. The company also intends to continue to develop new security and inspection products and technologies, including software, and to enhance current product and service offerings through internal research and development and selective acquisitions.

The company intends to continue to selectively enter new markets that complement its existing capabilities in the design, development and manufacture of specialized electronic systems and components for critical applications such as security inspection, patient monitoring and cardiology and remote monitoring. The company believes that by manufacturing products that rely on its existing technological capabilities, it will leverage its integrated design and manufacturing infrastructure to build a larger presence in new markets that present attractive competitive dynamics, intending to achieve this strategy through internal growth and through selective acquisitions. The company also expects to continue to seek acquisition opportunities to broaden its technological expertise and capabilities, lower its manufacturing costs and facilitate its entry into new markets.

The company's gross margin in fiscal year 2025 was relatively comparable to the prior year at 34.3% ²² of net revenues. Selling, general and administrative expense as a percentage of net revenues decreased from 17.5% ²³ in fiscal 2024 to 17.0% ²⁴ in fiscal 2025. The company has undertaken certain restructuring activities in an effort to align its global capacity and infrastructure with demand and fully integrate acquisitions, thereby improving operational efficiency, and may utilize similar measures in the future to further increase operating efficiencies. During fiscal 2025, restructuring and other charges were $5.3 million ²⁵, consisting of $0.7 million ²⁶ for facility closure costs, $2.7 million ²⁷ for employee terminations, $0.6 million ²⁸ in acquisition related costs, and $1.3 million ²⁹ in legal charges.

The company operates from multiple locations throughout the world and views its international operations as providing an important strategic advantage, allowing it to take advantage of competitive labor rates to lower manufacturing costs, strengthen sales and marketing efforts, and reduce delivery times to its global customer base. The company intends to continue to enhance its international manufacturing and sales capabilities. The company is in the process of implementing a new company-wide ERP system, which will modernize and replace many of its existing operating and financial systems. The company currently manufactures its security and inspection systems domestically in California, Massachusetts, and Tennessee, and internationally in Germany, Malaysia and the United Kingdom, and its patient monitoring and cardiology and remote monitoring systems in Washington state. The company outsources manufacturing of certain of its supplies and accessories.

Research and development expenses during fiscal 2025 were $73.4 million ³⁰, compared to $65.3 million ³¹ in the prior fiscal year. Net capital expenditures in fiscal 2025 were $23.8 million ³² compared to $22.1 million ³³ in the prior fiscal year. Expenditures for intangible and other assets in fiscal 2025 were $17.7 million ³⁴ compared to $17.3 million ³⁵ in the prior fiscal year. During fiscal 2025, the company repurchased 531,314 ³⁶ shares of common stock for $80.4 million ³⁷. As of June 30, 2025, 1,190,556 ³⁸ shares remained available for repurchase under the stock repurchase program. The company has not paid any dividends since its initial public offering in 1997 and has no intention of paying dividends for the foreseeable future.

The company faces headwinds from global macroeconomic factors including the supply chain environment, inflationary pressure, rising interest rates, and labor shortages. Increasing diplomatic and trade friction between the U.S. and China has created significant uncertainty in the global economy. Conflicts in Gaza and nearby regions have created political and economic uncertainty in the Middle East, and the continued conflict between Russia and Ukraine and the sanctions imposed in response have increased global economic and political uncertainty. The company has certain research and development activities within Ukraine for its Healthcare division which have been somewhat impacted. The company also faces headwinds from tariffs, noting that in 2025, the U.S. government announced the imposition of additional tariffs on certain goods imported from numerous countries, with multiple nations responding with reciprocal tariffs and other trade actions, which may materially increase costs and reduce margins.

The company faces risks from unfavorable currency exchange rate fluctuations, noting that a 10% appreciation of the U.S. dollar relative to local currency exchange rates would have resulted in a net increase in operating income of approximately $11.5 million ³⁹ in fiscal 2025, while a 10% depreciation would have resulted in a net decrease of approximately $11.5 million ⁴⁰. The company also faces risks from the lengthy and unpredictable sales cycles for its security and inspection systems, turnkey security screening solutions and patient monitoring and cardiology and remote monitoring systems, which often depend on governmental agency decisions and can involve lengthy approval processes. Additionally, the company faces risks from the competitive bidding process for contracts, which involves substantial costs and the possibility of protests that could delay or prevent contract awards.

The company faces significant product and professional liability risks if operators of, or algorithms installed on, its security and inspection systems fail to detect weapons, explosives or other devices used to commit a crime or terrorist act, for which adequate insurance coverage may not be available. The company's turnkey security screening solutions expose it to professional liability risks if contraband passes through its services. The company is subject to extensive U.S. Government procurement regulations, and non-compliance could result in termination of contracts, suspension, debarment, or False Claims Act litigation with treble damages and significant civil penalties. The company's revenues are dependent on orders with lengthy and unpredictable sales cycles, particularly for security and inspection systems and turnkey security screening solutions that depend on governmental agency decisions. The company faces risks from the conflict between Russia and Ukraine and the conflict in the Middle East, which have increased global economic and political uncertainty and have somewhat impacted its research and development activities in Ukraine. The company also faces risks from the imposition of tariffs by the U.S. government and retaliatory actions by other countries, which may materially increase costs and reduce margins.

Management's message emphasizes the company's position as a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications, with a growth strategy centered on capitalizing on global reach, vertical integration, the market for security and inspection systems, improving and complementing existing medical technologies, selectively entering new markets, and acquiring new technologies and companies. Key strategic priorities include leveraging expertise in designing and manufacturing cost-effective specialized electronic systems to gain price, performance and agility advantages over competitors, and translating such advantages into profitable growth in the security, healthcare and optoelectronics fields. Management also emphasizes the importance of international operations as a strategic advantage, the benefits of vertical integration in reducing costs and delivery times, and the intention to continue developing new products and technologies through internal research and development and selective acquisitions.